Rapid Micro Biosystems Valuation Multiples

Rapid Micro Biosystems Overview

About Rapid Micro Biosystems

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Founded

2006

HQ

Employees

163

Website

rapidmicrobio.com

Sectors

Laboratory ServicesMedical DevicesHealthTechDeepTech

Financials (LTM)

Revenue: $35M

EBITDA: ($42M)

EV

$90M

Valuation Multiples

Multiples.vc

Start free trial

Rapid Micro Biosystems Financials

Rapid Micro Biosystems reported last 12-month revenue of $35M and negative EBITDA of ($42M).

In the same LTM period, Rapid Micro Biosystems generated $5M in gross profit, ($42M) in EBITDA losses, and had net loss of ($45M).

Rapid Micro Biosystems P&L

In the most recent fiscal year, Rapid Micro Biosystems reported revenue of $34M and EBITDA of ($43M).

Rapid Micro Biosystems expects next 12-month revenue of XXX and NTM EBITDA of XXX

Rapid Micro Biosystems Stock Performance

Rapid Micro Biosystems has current market cap of $104M, and enterprise value of $90M.

Rapid Micro Biosystems' stock price is $2.28.

Rapid Micro Biosystems Valuation Multiples

Rapid Micro Biosystems trades at 2.5x EV/Revenue multiple, and (2.1x) EV/EBITDA.

Rapid Micro Biosystems Financial Valuation Multiples

As of April 20, 2026, Rapid Micro Biosystems has market cap of $104M and EV of $90M.

Equity research analysts estimate Rapid Micro Biosystems' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Rapid Micro Biosystems has a P/E ratio of (2.3x).

Rapid Micro Biosystems Margins & Growth Rates

Rapid Micro Biosystems' revenue in the last 12 month grew by 17%.

Rapid Micro Biosystems' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.

Rapid Micro Biosystems' rule of 40 is (78%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Rapid Micro Biosystems' rule of X is (52%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Rapid Micro Biosystems Public Comps

See public comps and valuation multiples for other Laboratory Services and Medical Devices comps.

Rapid Micro Biosystems M&A Activity

Rapid Micro Biosystems acquired XXX companies to date.

Last acquisition by Rapid Micro Biosystems was on XXXXXXXX, XXXXX. Rapid Micro Biosystems acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Rapid Micro Biosystems Investment Activity

Rapid Micro Biosystems invested in XXX companies to date.

Rapid Micro Biosystems made its latest investment on XXXXXXXX, XXXXX. Rapid Micro Biosystems invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).